Uvadex and Anaemia - a phase IV clinical study of FDA data

Summary:

Anaemia is reported as a side effect among people who take Uvadex (methoxsalen), especially for people who are female, 50-59 old, also take Heparin, and have Graft versus host disease.

The phase IV clinical study analyzes which people have Anaemia when taking Uvadex. It is created by eHealthMe based on reports of 597 people who have side effects when taking Uvadex from the FDA, and is updated regularly.

What is Uvadex?

Uvadex has active ingredients of methoxsalen. eHealthMe is studying from 597 Uvadex users. Check the latest studies of Uvadex.

What is Anaemia?

Anaemia (lack of blood) is found to be associated with 3,047 drugs and 3,939 conditions by eHealthMe. Check the latest studies of Anaemia.

On Jul, 09, 2026

597 people reported to have side effects when taking Uvadex.
Among them, 13 people (2.18%) have Anaemia.

Among these 13 people:

What is the gender of people who have Anaemia when taking Uvadex? *

female: 60 %
male: 40 %

What is the age of people who have Anaemia when taking Uvadex? *

What are other drugs people take besides Uvadex? *

Heparin: 3 people, 23.08%
Ciclosporin: 1 person, 7.69%

What are other side effects people have besides Anaemia? *

Heart Disease: 2 people, 15.38%
Death: 2 people, 15.38%
Hypotension (abnormally low blood pressure): 2 people, 15.38%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 2 people, 15.38%
Fever: 2 people, 15.38%
Vasoplegia Syndrome (low systemic vascular resistance): 1 person, 7.69%
Arrhythmias (irregular heartbeat): 1 person, 7.69%
Arteriovenous Fistula Thrombosis (formation of a blood clot inside a blood vessel-av fistula): 1 person, 7.69%
Bacterial Infection: 1 person, 7.69%
C-Reactive Protein Increased: 1 person, 7.69%

What are the existing conditions these people have? *

Lung Transplant Rejection (failure of lung transplant): 2 people, 15.38%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 15.38%
Transplant Rejection (a transplant material is not worked): 1 person, 7.69%
Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 1 person, 7.69%
Rash Papular (redness with papule): 1 person, 7.69%
Kidney Transplant Rejection: 1 person, 7.69%
Complications Of Transplanted Lung: 1 person, 7.69%
Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 1 person, 7.69%
Acute Graft Versus Host Disease In Skin (acute complication on skin following an allogeneic tissue/blood transplant): 1 person, 7.69%
Acute Graft Versus Host Disease In Liver (acute complication in liver following an allogeneic tissue/blood transplant): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Uvadex and have Anaemia?

- Check whether Anaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Uvadex:

Uvadex (597 reports)

Anaemia treatments and more:

Anaemia (269,298 reports)

Browse all side effects of Uvadex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Anaemia:

Anaemia (3,047 drugs)

Browse all the conditions that are associated with Anaemia:

Anaemia (3,939 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methoxsalen (the active ingredients of Uvadex) and Uvadex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.